Synergy and specificity in induction of gene activity by proinflammatory cytokines: Potential therapeutic targets

Shock

Volumn 7, Issue 6, 1997, Pages 405-412

  Spink, Jayne ^a   Cohen, Jonathan ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE;

ANIMAL; DRUG EFFECT; DRUG POTENTIATION; GENE EXPRESSION REGULATION; HUMAN; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; CYTOKINES; DRUG SYNERGISM; GENE EXPRESSION REGULATION; HUMANS; SIGNAL TRANSDUCTION;

EID: 0031154121     PISSN: 10732322     EISSN: None     Source Type: Journal    
DOI: 10.1097/00024382-199706000-00002     Document Type: Review

References (77)

1. Kuziel WA, Greene WC: InterIeukin-2 and the IL-2 receptor: New insights into structure and function. J Invest Dermatol 94:27S-32S, 1990.
2. Allouche M, Sahraoui Y, Augery-Bourqet Y, Perrakis M, Jasmin C, Georgoulias V: Interleukin 2 receptors. Leuk Res 14:699-703, 1990.
3. Kirken RA, Rui H, Evans GA, Farrar WL: Characterization of an interleukin-2 (IL-2)-induced tyrosine phosphorylated 116 kDa protein associated with the IL-2 receptor beta subunit. J Biol Chem 268:22765-22770, 1993.
4. Brockhaus M, Schoenfeld HJ, Schlaeger EJ, Hunziker W, Lesslauer W, Loetscher H: Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proc Natl Acad Sci USA 87:3127-3131, 1990.
5. Dembic Z, Loetscher H, Gubler U, et al: Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences. Cytokine 2:231-237, 1990.
6. Brenner DA, O'Hara M, Angel P, Chojkier M, Karin M: Prolonged activation of jun and collagenase genes by tumour necrosis factor-alpha. Nature 337:661-663, 1989.
7. Henkel T, Machleidt T, Alkalay I, Kronke M, Ben-Neriah Y, Baeuerle PA: Rapid proteolysis of I kappa B is necesary for activation of transcription factor NF-kappa B. Nature 365:182-185, 1993.
8. Klampfer L, Lee TH, Hsu W, Vilcek J, Chen-kiang S: NF-IL6 and AP-1 cooperatively modulate the activation of the TSG-6 gene by tumor necrosis factor-alpha and interleukin-1. Mol Cell Biol 14:6561-6569, 1994.
9. Brach MA, Gruss HJ, Scott C, Herrmann F: The mitogenic response to tumor necrosis factor-alpha requires c-jun/AP-1. Mol Cell Biol 13:4284-4290, 1993.
10. Mosley B, Dower SK, Gillis S, Cosman D: Determination of the minimum polypeptide lengths of the functionally active sites of human interleukins 1 alpha and 1 beta. Proc Natl Acad Sci USA 84:4572-4576, 1987.
11. Dinarello CA, Savage N: Interleukin 1 and its receptor. Crit Rev Immunol 9:1-20, 1989.
12. Farrar MA, Schreiber RD: The molecular cell biology of interferon-gamma and its receptor. Annu Rev Immunol 11:571-611, 1993.
13. Sorensen P, Muis AL-F, Krystal G: Interleukin-3 stimulates the tyrosine phosphorylation of the 140-kilodalton interleukin-3 receptor. J Biol Chem 264:19253-19258, 1989.
14. Shackelford DA, Towbridge IS: Ligand-stimulated tyrosine phosphorylation of the IL-2 receptor β chain and receptor-associated proteins. Cell Reg 2:73-85, 1991.
15. Wilks AF, Harpur AG, Kurban RR, Ralph SJ, Zurcher G, Ziemiecki A: Two novel protein-tyrosine kinases, each with a second phosphotransferase-related catalytic domain, define a new class of protein kinase. Mol Cell Biol 11:2057-2065, 1991.
16. Valazquez L, Fellous M, Stark GR, Pelligrini S: A protein tyrosine kinase in the interferon α/β signaling pathway. Cell 70:313-322, 1992.
17. Harpur, AG, Andres AC, Ziemiecki A, Aston RR, Wilks AF: JAK2, a third member of the JAK family of protein tyrosine kinases. Oncogene 7:1347-1353, 1992.
18. Hanks SK, Quinn AM, Hunter T: The protein kinase family: Conserved features and deduced phylogeny of the catalytic domains. Science 241: 42-52, 1988.
19. Horvath CM, Wen Z, Darnell JE Jr: A STAT protein domain that determines DNA sequence recognition suggests a novel DNA-binding domain. Genes Dev 9:984-994, 1995.
20. Schaffhausen B: SH2 domain structure and function. Biochim Biophys Acta 1242:61-75, 1995.
21. Kessler DS, Veals SA, Fu XY, Levy DE: Interferon-alpha regulates nuclear transclocation and DNA binding affinity of ISGF3, a multimeric transcriptional activator. Genes Dev 4:1753-1765, 1990.
22. Shuai K, Schindler C, Prezioso VR, Darnell JE Jr: Activation of transcription by IFN-gamma: Tyrosine phosphorylation of a 91 kD DNA binding protein. Science 258:1808-1812, 1992.
23. Qureshi SA, Salditt GM, Darnell JE Jr: Tyrosine-phoshporylated Stat1 and Stat2 plus a 48 kDa protein all contact DNA in forming ISGF3. Proc Natl Acad Science USA 92:3829-3833, 1995.
24. Quelle FW, Sato N, Wittuhn BA, et al: Jak2 associates with the beta c chain of the receptor for granulocyte-macrophage colony stimulating factor, and its activation requires the membrane-proximal region. Mol Cell Biol 14:4335-4341, 1994.
25. Tanaka N, Asao H, Ohbo K, et al: Physical association of Jak1 and Jak2 tyrosine kinases with the interleukin 2 receptor beta and gamma chains. Proc. Natl Acad Sci USA 91:7271-7275, 1994.
26. Asao H, Tanaka N, Ishii N, et al: Interleukin 2-induced activation of Jak3: possible involvement in signal transduction for c-myc induction and cell proliferation. FEBS Lett 351:201-206, 1994.
27. Igarashi K, Garotta G, Ozmen L, et al: Interferon-gamma induces tyrosine phosphorylation of interferon-gamma receptor and regulated association of protein tyrosine kinases, Jak1 and Jak2, with its receptor. J Biol Chem 269:14333-14336, 1994.
28. Stahl N, Boulton TG, Farruggella T, et al: Association and activation of Jak-Tyk kinases by CNTF-LIF-OSM-IL-6 beta receptor components. Science 263:92-95, 1994.
29. Narazaki M, Wittuhn BA, Yoshida K, Silvennoinen O, Yasukawa K, Ihle JN, Kishimoto T, Taga T: Activation of JAK2 kinase mediated by the interleukin 6 signal transducer gp130. Proc Natl Acad Sci USA 91:2285-2289, 1994.
30. Ihle, JN: STATs: Signal transducers and activators of transcription. Cell 84:331-334, 1996.
31. Siebenlist U, Franzoso G, Brown K: Structure, regulation and function of NF-κB. Annu Rev Cell Biol 10:405-455, 1994.
32. Urban MB, Baeuerle PA: The 65-kD subunit of NF-kappa B is a receptor for I kappa B and a modulator of DNA-binding specificity. Genes Dev 4:1975-1984, 1990.
33. Bours V, Franzosos G, Brown K, et al: Lymphocyte activation and the family of NF-kappa B transcription factor complexes. Curr Top Microbiol Immunol 182:411-420, 1992.
34. Kunsch C, Ruben SM, Rosen CA: Selection of optimal kappa B/Rel DNA-binding motifs: Interaction of both subunits of NF-kappa B with DNA is required for transcriptional activation. Mol Cell Biol 12:4412-4421, 1992.
35. Perkins ND, Schmid RM, Duckett CS, Leung K, Rice NR, Nabel GJ: Distinct combinations of NF-kappa B subunits determine the specificity of transcriptional activation. Proc Natl Acad Sci USA 89:1529-1533, 1992.
36. Siebenlist U, Franzoso G, Brown K: Structure, regulation and function of NF-kappa B. Annu Rev Cell Biol 10:405-55, 1994.
37. Fujita T, Nolan GP, Ghosh S, Baltimore D: Independent modes of transcriptional activation by the p50 and p65 subunits of NF-kappa B. Genes Dev 6:775-787, 1992.
38. Perkins ND, Schmid RM, Duckett CS, Leung K, Rice NR, Nabel GJ: Distinct combinations of NF-kappa B subunits determine the specificity of transcriptional activation. Proc Natl Acad Sci USA 89:1529-1533, 1992.
39. Finco TS, Baldwin AS Jr: Kappa B site-dependent induction of gene expression by diverse inducers of nuclear factor kappa B requires Raf-1. J Biol Chem 268:17676-17679, 1992.
40. Hohmann HP, Remy R, Poschl B, van Loon AP: Tumor necrosis factors-alpha and -beta bind to the same two types of tumor necrosis factor receptors and maximally activate the transcription factor NF-kappa B at low receptor occupancy and within minutes after receptor binding. J Biol Chem 265:15183-15188, 1990.
41. Croston GE, Cao Z, Goeddeel DV: NFκB activation by interleukin-1 (IL-1) requires an IL-1 receptor-associated protein kinase. J Biol Chem 270:16514-16517, 1995.
42. Osborn L, Kunkel S, Nabel GJ: Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. Proc Natl Acad Sci USA 86:2336-2340, 1989.
43. Messer G, Weiss EH, Baeuerle PA: Tumor necrosis factor beta (TNF-beta) induces binding of the NF-kappa B transcription factor to a high-affinity kappa B element in the TNF-beta promoter. Cytokine 2:389-97, 1990.
44. Hsu H, Xiong J, Goeddel DV: The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell 81:495-504, 1995.
45. Geller DA, Nguyen D, Shapiro RA, Nussler A, Di Silvo M, Freeswick P, Wang SC, Tweardy DJ, Simmons RL, Billiar TR: Cytokine induction of interferon regulatory factor-1 in hepatocytes. Surgery 114:235-242, 1993.
46. Darnell JE, Kerr IM, Stark GR: Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 264:1415-1421, 1994.
47. Zhong Z, Wen Z, Darnell JE Jr: Stat3: A STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 264:95-98, 1994.
48. Yamamoto K, Quelle FW, Thierfelder WE, et al: Stat4, a novel gamma interferon activation site-binding protein expressed in early myeloid differentiation. Mol Cell Biol 14:4342-4349, 1994.
49. Akira, S, Nishio Y, Inoue M, et al: Molecular cloning of APRF, a novel IFN-stimulated gene factor 3 p 91-related transcription factor involved in the gp130-mediated signaling pathway. Cell 77:63-71, 1994.
50. Wakao H, Gouilleux F, Groner B: Mammary gland factor (MGF) is a novel member of the cytokine regulated transcription gene family and confers the prolactin response. EMBO J 13:2182-2191, 1994.
51. Hou J, Schindler U, Henzel WJ, Ho TC, Brasseur M, McKnight SL: An interleukin-4-induced transcription factor: IL-4 Stat. Science 265:1701-6, 1994.
52. Jacobson NG, Szabo SJ, Weber-Nordt RM, et al: Interleukin 12 signalling in T helper type 1 (Th1) cells involves tyrosine phosphorylation of signal transducer and activator of transcription (Stat) 3 and Stat4. J Exp Med 181:1755-1762, 1995.
53. Giese K, Cox J, Grosschedl R: The HMG domain of lymphoid enhancer factor 1 bends DNA and facilitates assemble of functional nucleoprotein structures. Cell 69:185-195, 1992.
54. Paull TT, Haykinson MJ, Johnson RC: The nonspecific DNA-binding and -bending proteins HMG1 and HMG2 promote the assembly of complex nucleoprotein structures. Genes Dev 7:1521-1534, 1993.
55. Nissen MS, Reeves R: Changes is superhelicity are introduced into closed circular DNA by binding of high mobility group protein I/Y. J Biol Chem 270:4355-4360, 1995.
56. Thanos D, Maniatis T: Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome. Cell 83:1091-1100, 1995.
57. Abdulkadir SA, Krishna S, Thanos D, Maniatis T, Strominger JL, Ono SJ: Functional roles of the transcription factor Oct-2A and the high mobility group protein I/Y in HLA-DRA gene expression. J Exp Med 182:487-500, 1995.
58. Neish S, Read MA, Thanos D, Pine R, Maniatis T, Collins T: Endothelial interferon regulatory factor 1 cooperates with NF-kappa B as a transcriptional activator of vascular cell adhesion molecule 1. Mol Cell Biol 15:2558-2569, 1995.
59. Garoufalis E, Kwan I, Lin R, et al: Viral induction of the human beta interferon promoter: Modulation of transcription by NF-kappa B/rel proteins and interferon regulatory factors. J Virol 68:4707-4715, 1994.
60. Ten RM, Blank V, Le-Bail O, Kourilsky P, Israel A: Two factors, IRF1 and KBF1/NF-kappa B, cooperate during induction of MHC class I gene expression by interferon alpha beta or Newcastle disease virus. C R Acad Sci III 316:496-501, 1993.
61. Look DC, Pelletier MR, Tidwell RM, Roswit WT, Holtzman MJ: Stat1 depends on transcriptional synergy with Sp1. J Biol Chem 270:30264-30267, 1995.
62. Ohmori Y, Hamilton TA: The interferon-stimulated response element and a kappa B site mediate synergistic induction of murine IP-10 gene transcription by IFN-gamma and TNF-alpha. J Immunol 154:5235-5244, 1995.
63. Cohen J, Exley AR: Treatment of septic shock with antibodies to tumour necrosis factor. Schweiz Med Wochenschr 123:492-496, 1993.
64. Bodmer M, Fournel MA, Hinshaw LB: Preclinical review of anti-tumour necrosis factor monoclonal antibodies. Crit Care Med 21:5441-5446, 1993.
65. Fournel M: Study of septic shock in the non-human primate: Relationship of pathophysiological response to therapy with anti-TNF antibody. Circ Shock 44:221-229, 1994.
66. Steinshamn S, Bemelmans MHA, Buurman WA, Waage A: Granulocytopenia reduces release of soluble TNF receptor p 75 in endotoxin-stimulated mice: A possible mechanism of enhanced TNF activity. Cytokine 7:50-56, 1995.
67. Porteu F, Hieblot C: Tumor necrosis factor induces a selective shedding of its p75 receptor from human neutrophils. J Biol Chem 269:2834-2840, 1994.
68. Norman J, Franz M, Messina J, et al: Interleukin-1 receptor antagonist decreases severity of experimental acute pancreatitis. Surgery 117:648-655, 1995.
69. Valette JD Jr, Goldberg RN, Suguihara C, et al: Effect of an interleukin-1 receptor antagonist on the hemodynamic manifestations of group B streptococcal sepsis. Pediatr Res 38:701-708, 1995.
70. Fry DW, Bridges AJ: Inhibitors of protein tyrosine kinases. Curr Opin Biotechnol 6:662-667, 1995.
71. Burke TR Jr, Barchi JJ Jr, George C, Wolf G, Shoelson SE, Yan X: Conformationally constrained phosphotyrosyl memetics designed as monomeric Src homology 2 domain inhibitors. J Med Chem 38:1386-1396, 1995.
72. Goodchild J: Oligodeoxynucleotides. In: Cohen J, (ed): Antisense Inhibitors of Gene Expression. Macmillan Press, London: pp 53-71, 1989.
73. Moriya K, Matsukura M, Kurokawa K, Koike K: In vivo inhibition of hepatitis B virus gene expression by antisense phophorothioate oligonucleotides. Biochem Biophys Res Commun 218:217-223, 1996.
74. Mizutani T, Kato N, Hirota M, Sugiyama K, Murakami A, Shimotohno K: Inhibition of hepatitis C virus replication by antisense oligonucleotide in culture cells. Biochem Biophys Res Commun 212:906-911, 1995.
75. Skorski T, Nieborowska-Skorska M, Campbell K, et al: Leukemia treatment in severe combined immunodeficiency mice by antisense oligodeoxynucleotides targeting cooperating oncogenes. J Exp Med 182:1645-1653, 1995.
76. Watson JM, Berek JS, Martinez-Maza O: Growth inhibition of ovarian cancer cells induced by antisense IL-6 oligonucleotides. Gynecol Oncol 49:8-15, 1993.
77. Autieri MV, Yue TL, Ferstein GZ, Ohlstein E: Antisense oligonucleotides to the p65 subunit of NF-kB inhibit human vascular smooth muscle cell adherence and proliferation and prevent neointima formation in rat carotid arteries. Biochem Biophys Res Commun 213:827-836, 1995.